Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
…, J van Schooten, MJ van Breemen, TPL Bijl… - Science, 2020 - science.org
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had a large impact on global health, travel, and economy. Therefore, preventative and …
had a large impact on global health, travel, and economy. Therefore, preventative and …
[HTML][HTML] Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
The development of native-like HIV-1 envelope (Env) trimer antigens has enabled the induction
of neutralizing antibody (NAb) responses against neutralization-resistant HIV-1 strains in …
of neutralizing antibody (NAb) responses against neutralization-resistant HIV-1 strains in …
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
…, JA Burger, M Poniman, M Oomen, D Eggink, TPL Bijl… - Elife, 2021 - elifesciences.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
[PDF][PDF] Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
…, Y Watanabe, M Claireaux, HR Perrett, TPL Bijl… - Cell Host & Microbe, 2022 - cell.com
The Lassa virus is endemic in parts of West Africa, and it causes hemorrhagic fever with high
mortality. The development of a recombinant protein vaccine has been hampered by the …
mortality. The development of a recombinant protein vaccine has been hampered by the …
[HTML][HTML] A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
…, I Bontjer, JA Burger, M Poniman, TPL Bijl… - Nature …, 2022 - nature.com
Delineating the origins and properties of antibodies elicited by SARS-CoV-2 infection and
vaccination is critical for understanding their benefits and potential shortcomings. Therefore, …
vaccination is critical for understanding their benefits and potential shortcomings. Therefore, …
[PDF][PDF] Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
Targeting germline (gl-) precursors of broadly neutralizing antibodies (bNAbs) is acknowledged
as an important strategy for HIV-1 vaccines. The VRC01-class of bNAbs is attractive …
as an important strategy for HIV-1 vaccines. The VRC01-class of bNAbs is attractive …
[HTML][HTML] COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
…, R Rathnasinghe, PJM Brouwer, TPL Bijl… - Nature …, 2021 - nature.com
Effective treatments against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2)
are urgently needed. Monoclonal antibodies have shown promising results in patients. …
are urgently needed. Monoclonal antibodies have shown promising results in patients. …
[HTML][HTML] Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a
dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate …
dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate …
[HTML][HTML] Comparison of SARS-CoV-2-specific antibodies in human milk after mRNA-based COVID-19 vaccination and infection
HG Juncker, SJ Mulleners, MJ van Gils, TPL Bijl… - Vaccines, 2021 - mdpi.com
SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated
lactating women and might provide protection to the breastfed infant against COVID-19. …
lactating women and might provide protection to the breastfed infant against COVID-19. …
[HTML][HTML] Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
…, M Claireaux, TG Caniels, JL Snitselaar, TPL Bijl… - Iscience, 2023 - Elsevier
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has remained a medical threat due to the evolution of multiple variants that acquire resistance …
has remained a medical threat due to the evolution of multiple variants that acquire resistance …
